Elisabeth Cardis is Research Professor in Radiation Epidemiology at ISGlobal. Before moving to CREAL (now ISGlobal Campus MAR) in April 2008, she was the head of the Radiation Group at IARC in Lyon, where she coordinated studies of ionising and non-ionising radiation for over 20 years. She was a visiting scientist at the Radiation Effects Research Foundation in Hiroshima, Japan, in 1981-2 and received a PhD in Biostatistics from the School of Public Health of the University of Washington in Seattle, in 1985.
Lines of Research
She is the author of over 100 indexed publications. She is a member of the board of the MELODI (Multidisciplinary European Low Dose Initiative) platform and is on the advisory board of the Israeli Information Centre for Non-Ionising Radiation and member of the radiofrequency working group of the French Agency for Food, Environmental and Occupational Health & Safety (which she chaired until 2013). She is an affiliate of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada. She chaired the IARC Monographs working group on Ionising Radiation and UV and was member of the High Level Expert Group on European Low Dose Risk Research, of the Steering Committee for the Swiss National Non-Ionising Radiation Programme, the Spanish Evaluation Committee on Radiofrequency and Health, the US National Academy of Sciences BEIR VII Committee, of the Expert Group on Health for the UN Chernobyl Forum and of the project management board of EMF-Net, the steering committee of the EU funded EFHRAN project (EMF risk assessment coordination network), the scientific advisory board of the WHO International EMF project and a corresponding member of ICNIRP and consultant to the United Nations Scientific Committee on the Effects of Atomic Radiation.
She has extensive experience in coordinating and participating in major international research projects: as coordinator (EC FP7 funded GERoNiMO, MOBI-Kids; FP6 Gene-Rad-Risk; FP5 INTERPHONE, 15-country nuclear workers study, CHILD-THYR, THYR-RISK; US NIH INTEROCC) and as WP/task leader and member of Project Board/Project Management Group and Steering Committees of a large number of high-profile national and international studies including EC projects (Alpha-Risk, ARCH, DoReMi, EFHRAN, EMF-Net, Epi-CT, OPERRA).
- Grellier J, Ravazzani P, Cardis E. Potential health impacts of residential exposures to extremely low frequency magnetic fields in Europe. Environ Int. 2014 Jan;62:55-63. PMID: 24161447
- Damiola F, Byrnes G, Moissonnier M, Pertesi M, Deltour I, Fillon A, Le Calvez-Kelm F, Tenet V, McKay-Chopin S, McKay JD, Malakhova I, Masyakin V, Cardis E, Lesueur F, Kesminiene A. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation. Int J Cancer. 2013 Sep 17. doi: 10.1002/ijc.28483. [Epub ahead of print]. PMID: 24105688
- Pernot E, Hall J, . Baatout S; Benotmane, E. Blanchardon, S. Bouffler, H. El-Saghire, M. Gomolka, A. Guertler, M. Harms-Ringdahl, P.A. Jeggo, M. Kreuzer, D. Laurier, C. Lindholm, R. M’kacher, R. Quintens, K. Rothkamm, L. Sabatier, S. Tapio, F. De Vathaire, E. Cardis, Ionising radiation biomarkers for potential use in epidemiological studies. Mutat Res. 2012 Oct-Dec;751(2):258-86. doi: 10.1016/j.mrrev.2012.05.003.
- Kesminiene A, Evrard A.S., Ivanov V, Malakhova I, Kurtinaitis J, Stengrevics A, Tekkel M, Bouville A, Chekin S, Drozdovitch V, Gavrilin Y, Golovanov I, Krjuchkov V, Maceika E, Mirkhaidarov A, Polyakov S, Tenet V, Tukov A, Cardis E. Risk of thyroid cancer among Chernobyl liquidators. Radiat Res. 2012 Nov;178(5):425-36. doi: 10.1667/RR2975.1. Epub 2012 Sep 21
- Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, GENEPSO, Noguès C, Gauthier-Villars M, Lasset C, Fricker JP, EMBRACE, Peock S, Frost D, Evans DG, Eeles RA, Paterson J, HEBON, Manders P, van Asperen CJ, Ausems M.G.E.M, Meijers-Heijboer H, Thierry-Chef I, Hauptmann M, Goldgar D, Rookus MA, van Leeuwen F. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. 2012 Sep 6;345:e5660. doi: 10.1136/bmj.e5660.